<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0213-9111</journal-id>
<journal-title><![CDATA[Gaceta Sanitaria]]></journal-title>
<abbrev-journal-title><![CDATA[Gac Sanit]]></abbrev-journal-title>
<issn>0213-9111</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Española de Salud Pública y Administración Sanitaria (SESPAS)]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0213-91112024000100220</article-id>
<article-id pub-id-type="doi">10.1016/j.gaceta.2024.102433</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Consumption of hypnosedatives in Spain: characterization and time trends, 2005-2022]]></article-title>
<article-title xml:lang="es"><![CDATA[Consumo de hipnosedantes en España: caracterización y tendencias temporales, 2005-2022]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mourino]]></surname>
<given-names><![CDATA[Nerea]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Teijeiro]]></surname>
<given-names><![CDATA[Ana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Guerra-Tort]]></surname>
<given-names><![CDATA[Carla]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rey-Brandariz]]></surname>
<given-names><![CDATA[Julia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Candal-Pedreira]]></surname>
<given-names><![CDATA[Cristina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Martín-Gisbert]]></surname>
<given-names><![CDATA[Lucía]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mascareñas-García]]></surname>
<given-names><![CDATA[Marta]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[Guadalupe]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Varela-Lema]]></surname>
<given-names><![CDATA[Leonor]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
<xref ref-type="aff" rid="A a"/>
<xref ref-type="aff" rid="A3"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pérez-Ríos]]></surname>
<given-names><![CDATA[Mónica]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
<xref ref-type="aff" rid="A a"/>
<xref ref-type="aff" rid="A3"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,University of Santiago de Compostela Department of Preventive Medicine and Public Health ]]></institution>
<addr-line><![CDATA[Santiago de Compostela A Coruña]]></addr-line>
<country>Spain</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,CIBER de Epidemiología y Salud Pública (CIBERESP)  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Spain</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Health Research Institute of Santiago de Compostela (Instituto de Investigación Sanitaria de Santiago de Compostela-IDIS)  ]]></institution>
<addr-line><![CDATA[Santiago de Compostela A Coruña]]></addr-line>
<country>Spain</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2024</year>
</pub-date>
<volume>38</volume>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S0213-91112024000100220&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S0213-91112024000100220&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S0213-91112024000100220&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Objective: To analyze the evolution of hypnosedative use in the Spanish population aged 15 to 64 (2005-2022), identifying regional variations and changes in users profile.  Method: We used data from the Survey on the Use of Alcohol and other Drugs in Spain. Past 30-day use was analyzed by sex, age and autonomous community between 2005 and 2022. A multivariate logistic regression was used to identify characteristics of consumption; the temporal trend of prevalence and adjusted odds ratio were evaluated using joinpoint regression models.  Results: Between 2005 and 2022, the prevalence of hypnosedative use in Spain increased (from 3.7% to 9.7%) with an annual percentage change of 4.7%. The maximum increase was observed among women aged 55 to 64, reaching a prevalence of 21.4% in 2022. Use increased in all autonomous communities, with Cantabria, La Rioja and Andalusia standing out. The likelihood of using hypnosedatives was higher among women, the oldest age groups, those with basic or intermediate education, those unemployed or economically inactive, those not living with a partner or family, Spanish citizens, and tobacco or cannabis users.  Conclusions: An upward trend in the use of hypnosedatives in Spain has been observed since 2005, with variations according to sex, age, and autonomous community. It is crucial to update regional addiction plans, promote preventive strategies and foster collaboration between health authorities, medical professionals and the population to address mental health inequalities and ensure adequate care and responsible prescribing.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Objetivo: Analizar la evolución del consumo de hipnosedantes en la población española de 15 a 64 años desde 2005 hasta 2022, identificando variaciones regionales y cambios en el perfil de los consumidores.  Método: Se utilizaron datos de la Encuesta sobre Uso de Alcohol y otras Drogas en España. Se analizó el consumo en los últimos 30 días, desglosado por sexo, edad y comunidad autónoma entre 2005 y 2022. Se realizó una regresión logística multivariante para identificar las características asociadas al consumo y se evaluó la tendencia temporal de las prevalencias y las odds ratio ajustadas utilizando modelos de regresión joinpoint.  Resultados: Entre 2005 y 2022 aumentó la prevalencia de consumo (del 3,7% al 9,7%), con un porcentaje de cambio anual del 4,7%. El mayor incremento se observó en mujeres de 55 a 64 años, alcanzando una prevalencia de 21,4% en 2022. En todas las comunidades autónomas aumentó el consumo, destacando Cantabria, La Rioja y Andalucía. La probabilidad de consumir hipnosedantes fue mayor en las mujeres, en los de mayor edad, con nivel educativo básico o medio, desempleados o inactivos laboralmente, que no conviven con pareja o familia, de nacionalidad española y consumidores de tabaco o cannabis.  Conclusiones: En España se observa un aumento del consumo de hipnosedantes desde 2005, con variaciones por sexo, edad y comunidad autónoma. Es crucial actualizar los planes regionales de adicciones, promover estrategias preventivas y la colaboración entre autoridades sanitarias, profesionales médicos y la población para abordar las desigualdades en salud mental y asegurar una atención adecuada y una prescripción responsable.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Hypnotics and sedatives]]></kwd>
<kwd lng="en"><![CDATA[Prevalence]]></kwd>
<kwd lng="en"><![CDATA[Spain]]></kwd>
<kwd lng="en"><![CDATA[Adults]]></kwd>
<kwd lng="en"><![CDATA[Addictive behavior]]></kwd>
<kwd lng="es"><![CDATA[Hipnóticos y sedantes]]></kwd>
<kwd lng="es"><![CDATA[Prevalencia]]></kwd>
<kwd lng="es"><![CDATA[España]]></kwd>
<kwd lng="es"><![CDATA[Adultos]]></kwd>
<kwd lng="es"><![CDATA[Conducta adictiv]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<collab>World Health Organization</collab>
<source><![CDATA[International Classification of Diseases 11th Revision (ICD-11)]]></source>
<year>2022</year>
<publisher-loc><![CDATA[Geneva ]]></publisher-loc>
<publisher-name><![CDATA[WHO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<collab>World Health Organization</collab>
<source><![CDATA[World mental health report: transforming mental health for all]]></source>
<year>2022</year>
<publisher-loc><![CDATA[Geneva ]]></publisher-loc>
<publisher-name><![CDATA[WHO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="">
<collab>Global Health Data Exchange</collab>
<source><![CDATA[Seattle: Institute for Health Metrics and Evaluation]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<collab>COVID-19 Mental Disorders Collaborators</collab>
<article-title xml:lang=""><![CDATA[Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2021</year>
<volume>398</volume>
<page-range>1700-12</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carrasco-Garrido]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández-Barrera]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez-Trujillo]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Time trend in psychotropic medication use in Spain: a nationwide population-based study]]></article-title>
<source><![CDATA[Int J Environ Res Public Health]]></source>
<year>2016</year>
<volume>13</volume>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brauer]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Alfageh]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Blais]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Psychotropic medicine consumption in 65 countries and regions, 2008-19: a longitudinal study]]></article-title>
<source><![CDATA[Lancet Psychiatry]]></source>
<year>2021</year>
<volume>8</volume>
<page-range>1071-82</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sánchez Díaz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Martín-Calvo]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Mateos-Campos]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Trends in the use of anxiolytics in Castile and Leon, Spain, between 2015-2020: evaluating the impact of COVID-19]]></article-title>
<source><![CDATA[Int J Environ Res Public Health]]></source>
<year>2021</year>
<volume>18</volume>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="">
<collab>Agencia Española de Medicamentos y Productos Sanitarios</collab>
<source><![CDATA[Utilización de medicamentos ansiolíticos e hipnóticos en España. 2010-2021]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[González-López]]></surname>
<given-names><![CDATA[MDC]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz-Calvo]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz-González]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Consumption of psychiatric drugs in primary care during the COVID-19 pandemic]]></article-title>
<source><![CDATA[Int J Environ Res Public Health]]></source>
<year>2022</year>
<volume>19</volume>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="book">
<source><![CDATA[Ministerio de Sanidad. Encuesta sobre alcohol y otras drogas en España, EDADES 2022]]></source>
<year>2022</year>
<publisher-name><![CDATA[Secretaría General de Sanidad; Delegación del Gobierno para el Plan Nacional Sobre Drogas]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lader]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Benzodiazepine harm: how can it be reduced?]]></article-title>
<source><![CDATA[Br J Clin Pharmacol]]></source>
<year>2014</year>
<volume>77</volume>
<page-range>295-301</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<collab>Norwegian Institute of Public Health</collab>
<source><![CDATA[ATC/DDD Index 2024]]></source>
<year>2024</year>
<publisher-name><![CDATA[WHO Collaborating Centre for Drug Statistics Methodology]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sane Schepisi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Di Napoli]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Asciutto]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The 2008 financial crisis and changes in lifestyle-related behaviors in Italy, Greece, Spain, and Portugal: a systematic review]]></article-title>
<source><![CDATA[Int J Environ Res Public Health]]></source>
<year>2021</year>
<volume>18</volume>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Milani]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Raji]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Trends in the use of benzodiazepines, Z-hypnotics, and serotonergic drugs among US women and men before and during the COVID-19 pandemic]]></article-title>
<source><![CDATA[JAMA Netw Open]]></source>
<year>2021</year>
<volume>4</volume>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García Diez]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[De Nicolás Valdés]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Diéguez Varela]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[[Impact of COVID-19 lockdown on the prescription of benzodiazepines]]]></article-title>
<source><![CDATA[Aten Primaria]]></source>
<year>2023</year>
<volume>55</volume>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="book">
<collab>Ministerio de Sanidad.Consumo y Bienestar Social</collab>
<source><![CDATA[Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, ESTUDES. Plan Nacional sobre Drogas]]></source>
<year>2023</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Ministerio de Sanidad, Consumo y Bienestar Social]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="">
<source><![CDATA[ESPAD Report 2019 - Resultados del Proyecto Europeo de Encuesta Escolar sobre Alcohol y otras Drogas. 1995-2019]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bacigalupe]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[González-Rábago]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez-Carrillo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[[Gender inequality and mental health medicalization: sociocultural determining factors from the analysis of expert perceptions]]]></article-title>
<source><![CDATA[Aten Primaria]]></source>
<year>2022</year>
<volume>54</volume>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ross-Durow]]></surname>
<given-names><![CDATA[PL]]></given-names>
</name>
<name>
<surname><![CDATA[McCabe]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
<name>
<surname><![CDATA[Boyd]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adolescents' access to their own prescription medications in the home]]></article-title>
<source><![CDATA[J Adolesc Health]]></source>
<year>2013</year>
<volume>53</volume>
<page-range>260-4</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez-Mendia]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Bacigalupe de la Hera]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Martín Roncero]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[[Gender inequalities in the consumption of anxiolytics and hypnosedatives by adolescents in Spain: a cross-sectional study]]]></article-title>
<source><![CDATA[Rev Esp Salud Publica]]></source>
<year>2023</year>
<volume>97</volume>
</nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="">
<collab>Instituto Nacional de Estadística</collab>
<source><![CDATA[Encuesta Europea de Salud 2020. Problemas o enfermedades crónicas o de larga evolución padecidas en los últimos 12 meses y diagnosticadas por un medico según sexo y comunidad autónoma]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="">
<collab>Instituto Nacional de Estadistica</collab>
<source><![CDATA[Índice de envejecimiento por comunidad autónoma]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Teixidó-Compañó]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Espelt]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sordo]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Differences between men and women in substance use: the role of educational level and employment status]]></article-title>
<source><![CDATA[Gac Sanit]]></source>
<year>2018</year>
<volume>32</volume>
<page-range>41-7</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="">
<collab>Instituto Nacional de Estadística</collab>
<source><![CDATA[Tasa de paro de la población de 16 y más años por sexo y comunidad autónoma]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="book">
<collab>Secretaría General de Servicios Sociales</collab>
<source><![CDATA[III Plan Andaluz sobre Drogas y Adicciones (2016-2021)]]></source>
<year>2016</year>
<publisher-name><![CDATA[Consejería de Igualdad y Políticas Sociales]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ruiz-Cantero]]></surname>
<given-names><![CDATA[MT]]></given-names>
</name>
<name>
<surname><![CDATA[Verdú-Delgado]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[[Gender bias in treatment]]]></article-title>
<source><![CDATA[Gac Sanit]]></source>
<year>2004</year>
<volume>18</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>118-25</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maestre-Miquel]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[López-de-Andrés]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ji]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Gender differences in the prevalence of mental health, psychological distress and psychotropic medication consumption in Spain a nationwide population-based study]]></article-title>
<source><![CDATA[Int J Environ Res Public Health]]></source>
<year>2021</year>
<volume>18</volume>
</nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Teixidó-Compañó]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Espelt]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sordo]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Differences between men and women in substance use the role of educational level and employment status]]></article-title>
<source><![CDATA[Gac Sanit]]></source>
<year>2018</year>
<volume>32</volume>
<page-range>41-7</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yusuf]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Adose]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Basnet]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Enhancing community-oriented care implementation of social prescribing within a family health team]]></article-title>
<source><![CDATA[Healthc Manage Forum]]></source>
<year>2024</year>
<volume>37</volume>
<numero>1 Suppl</numero>
<issue>1 Suppl</issue>
<page-range>33-7S</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hahn]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Truman]]></surname>
<given-names><![CDATA[BI]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Education improves public health and promotes health equity]]></article-title>
<source><![CDATA[Int J Health Serv]]></source>
<year>2015</year>
<volume>45</volume>
<page-range>657-78</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zimmerman]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Woolf]]></surname>
<given-names><![CDATA[SH]]></given-names>
</name>
</person-group>
<source><![CDATA[Understanding the Relationship Between Education and Health]]></source>
<year>2014</year>
<publisher-name><![CDATA[NAM Perspect]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Goodwin]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Understanding integrated care]]></article-title>
<source><![CDATA[Int J Integr Care]]></source>
<year>2016</year>
<volume>16</volume>
</nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martín Álvarez]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Barrientos Marín]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Millán]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The relationship between the socio-economic gradient and cigarette consumption in Spain]]></article-title>
<source><![CDATA[Adicciones]]></source>
<year>2022</year>
<volume>34</volume>
<page-range>94-109</page-range></nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Latkin]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Edwards]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Davey-Rothwell]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The relationship between social desirability bias and self-reports of health, substance use, and social network factors among urban substance users in Baltimore, Maryland]]></article-title>
<source><![CDATA[Addict Behav]]></source>
<year>2017</year>
<volume>73</volume>
<page-range>133-6</page-range></nlm-citation>
</ref>
<ref id="B35">
<label>35</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tucker]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Härmä]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ojajärvi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Association of rotating shift work schedules and the use of prescribed sleep medication a prospective cohort study]]></article-title>
<source><![CDATA[J Sleep Res]]></source>
<year>2021</year>
<volume>30</volume>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
